In another transaction, Kuber India Fund sold 113,468 shares of Windlas Biotech at Rs. 379.7 apiece through a bulk deal on the NSE.

The shares that were issued at ₹1,618 each opened trading at ₹1,600 on the BSE and fell to a low of ₹1,476 in early trade before closing at...

Shares of Devyani International listed at a premium of more than 56% to their offer price while the other three companies that debuted alon...

Astha Jain of Hem Securities suggested that investors should book partial profits in Krsnaa Diagnostics and Exxaro Tiles.

The IPO by the Dehradun-based pharma formulations company ran from August 4 to August 6 and was sold in the Rs 448-460 range.

Premia of these listing candidates in the unofficial market were hammered badly after sentiment in the second rung stocks took a hit, subsc...

The three-day IPO received bids for 13,77,39,750 shares against 61,36,252 shares on offer, as per NSE data.

The company has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, according ...

Windlas Biotech has already decided to allocate 26,18,706 equity shares at Rs 460 apiece to 22 funds aggregating to Rs 120.46 crore, accord...

The Rs 401 crore issue received applications for 63,38,730 shares out of on-offer 61,36,252 shares, meaning a subscription of slightly over...

The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will...

They include Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech, which are going to raise close to Rs 3,614 crore ...

Analysts and traders expect the issues to sail through given the demand for fresh issues in the market. The grey market premium has also ju...

Windlas Biotech will raise Rs 165 crore through the issuance of fresh equity shares, while promoters and existing shareholders will offload...

The company is into domestic pharmaceutical formulations contract development and manufacturing business.

Aermed, is an online pharmacy store that allows you to order medicines online that get delivered at your doorstep within 24 hours.

Granules said it will be responsible for the marketing and distribution of the products in the US, subject to the final approval by the US ...